NOAC Monotherapy Safe, Effective in Patients With AF Undergoing PCI With DES: ADAPT AF-DES Study

Join our community to access additional content!

CRT Community

$0.00

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Join Now!
Already have an account? Login Now

CRT Community Premium

$650.00 annually

Register for Meetings

“In The News” & “Cardiovascular Marketplace” Content Access

Listen to Podcasts

Watch On-Demand Content

CardioTube Access

Access to Recorded Live Broadcasts from CRTvirtual Meetings, DMV, & Cath Conference

Access Recorded Interviews

Download PPT Slide Decks

Complimentary subscription to electronic version of the CRM Journal

Access to CRT Meeting Registration Discounts

CRT Premium Content, including on-demand videos and presentation downloads

Join Now!
Already have an account? Login Now
News

NOAC Monotherapy Safe, Effective in Patients With AF Undergoing PCI With DES: ADAPT AF-DES Study

Posted: 11/09/2025
Author:
Bailey G. Salimes, CRTonline.org
News Articles 2025 Conference ACS & AMI Percutaneous Coronary Intervention Meetings Coronary Interventions Bleeding Complications Coronary Drug Eluting Stent (DES)Antiplatelet Therapy Cardiovascular Pharmacology News AHA Late-Breaking Trials

Non-vitamin K antagonist oral anticoagulant (NOAC) monotherapy is noninferior to combination therapy, NOAC plus clopidogrel, after percutaneous coronary intervention (PCI) with a contemporary drug-eluting stent (DES) in patients with atrial fibrillation (AF), results from the ADAPT AF-DES trial show.
1-3 of 4426 results
1 2 3 4 5 Next »

Breaking News: Philips Acquiring SpectraWAVE Inc.

Dec 15, 2025 by
Bailey G. Salimes, CRTonline.org

Philips (Amsterdam, the Netherlands) agreed to acquire SpectraWAVE Inc. (Bedford, Massachusetts) today, Philips declared in a news release. This includes SpectraWAVE’s state-of-the-art vascular imaging software.

Evolocumab Provides Stronger Heart Protection in Patients With Obesity, FOURIER Analysis Finds

Dec 15, 2025 by
Will Chu, CRTonline.org

The cholesterol-lowering drug evolocumab may provide substantial heart-protective benefits in patients with obesity and cardiovascular disease, according to a new study.

Social Needs Impacting Health Influence Frequency of ER Visits and Inpatient Hospital Stays: Cohort Study

Dec 15, 2025 by
Bailey G. Salimes, CRTonline.org

Health-related social needs, such as the need for housing stability, food security or reliable transportation, are observed in many emergency department (ED) patients, a new study shows.

1-3 of 4426 results
1 2 3 4 5 Next »

Most Viewed Pages

Evaluation of Transcatheter Aortic Valve Stent Frame Expansion Using IVUS

A TAVR Using the Pi-Cardia ShortCut Catheter with a Navitor

Routine Post-Dilatation at Nominal Volume to Optimize the Expansion of Balloon-Expandable Valves: the DOUBLE-TAP Study

TAVR With Balloon Versus Self-Expandable Bioprostheses for the Treatment

TAVR vs balloon aortic valvotomy for severe aortic stenosis and cardiogenic shock: An insight from the National Inpatient Sample database

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Join our community to access additional content!

CRT Community

CRT Community Premium

News

NOAC Monotherapy Safe, Effective in Patients With AF Undergoing PCI With DES: ADAPT AF-DES Study

Breaking News: Philips Acquiring SpectraWAVE Inc.

Evolocumab Provides Stronger Heart Protection in Patients With Obesity, FOURIER Analysis Finds

Social Needs Impacting Health Influence Frequency of ER Visits and Inpatient Hospital Stays: Cohort Study

Most Viewed Pages

Explore the Site

Stay Connected